AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3687313 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY m 1099 (3 X 50 mg/day) in non-diabetic controls
Number of subjects: 6
Study 3687313 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY m 1099 (2 X 25 mg/day) in type II diabetics
Number of subjects: 6
Study 3687313 — intervention group
Group type: COMPARATOR
Intervention: BAY o 1248 (15 mg single dose) in type II diabetics
Number of subjects: 6
Study 29752922 — intervention group
Group type: EXPERIMENTAL
Intervention: Transabdominal sonography (TAS)
Number of subjects: 629
Study 29752922 — intervention group
Group type: COMPARATOR
Intervention: Transvaginal sonography (TVS)
Number of subjects: 629
Study 27871302 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate
Number of subjects: 42
Study 27871302 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine hydrobromide
Number of subjects: 42
Study 27871302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 25003151 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose remifentanil (10 ng · mL(‐1))
Number of subjects: 126
Study 25003151 — intervention group
Group type: COMPARATOR
Intervention: Low-dose remifentanil (5 ng · mL(‐1))
Number of subjects: 126
Study 22370325 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant (250 mg + LD regimen) plus 1 mg of anastrozole daily
Number of subjects: 514
Study 22370325 — intervention group
Group type: COMPARATOR
Intervention: Anastrozole (1 mg daily) alone
Number of subjects: 514
Study 22370325 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant plus anastrozole
Number of subjects: 514
Study 22370325 — intervention group
Group type: COMPARATOR
Intervention: Anastrozole alone
Number of subjects: 514
Study 20088854 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist of Nonverbal Pain Indicators (CNPI)
Number of subjects: 60
Study 20088854 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Assessment in Advanced Dementia (PAINAD)
Number of subjects: 60
Study 19100067 — intervention group
Group type: EXPERIMENTAL
Intervention: Autoantibodies against beta(1) adrenergic receptor
Number of subjects: 136
Study 19100067 — intervention group
Group type: EXPERIMENTAL
Intervention: Autoantibodies against M(2) adrenergic receptor
Number of subjects: 136
Study 15696402 — intervention group
Group type: COMPARATOR
Intervention: NUTRIOSE FB 30 g/d
Number of subjects: 20
Study 15696402 — intervention group
Group type: COMPARATOR
Intervention: NUTRIOSE FB 45 g/d
Number of subjects: 20
Study 15696402 — intervention group
Group type: COMPARATOR
Intervention: NUTRIOSE FB 60 g/d
Number of subjects: 20
Study 15696402 — intervention group
Group type: COMPARATOR
Intervention: NUTRIOSE FB 80 g/d
Number of subjects: 20
Study 15696402 — intervention group
Group type: COMPARATOR
Intervention: NUTRIOSE FB 10 g/d to 80 g/d
Number of subjects: 20
Study 12133372 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification
Number of subjects: 68
Study 10362215 — intervention group
Group type: EXPERIMENTAL
Intervention: VT resolution during the first year of life
Number of subjects: 98
Study 10362215 — intervention group
Group type: EXPERIMENTAL
Intervention: VT resolution beyond the first year of life
Number of subjects: 98
Study 10362215 — intervention group
Group type: EXPERIMENTAL
Intervention: Presumed right VT
Number of subjects: 98
Study 10362215 — intervention group
Group type: EXPERIMENTAL
Intervention: Presumed left VT
Number of subjects: 98
Study 10362215 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients free of VT and not taking antiarrhythmic drugs at last follow-up
Number of subjects: 98
Study 7562100 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week moderately energy-restricted diet (80% of habitual)
Number of subjects: 24
Study 7562100 — intervention group
Group type: COMPARATOR
Intervention: Control group (8 subjects)
Number of subjects: 24
Study 2257739 — intervention group
Group type: EXPERIMENTAL
Intervention: Gyne T 380 Slimline
Number of subjects: 996
Study 2257739 — intervention group
Group type: COMPARATOR
Intervention: Standard Gyne T 380
Number of subjects: 996
Study 2257739 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 996
Study 941864 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture therapy in three different loci (unilateral loci used for weight loss, bilateral loci, unilateral loci not used for weight loss)
Number of subjects: 24
Study 941864 — intervention group
Group type: COMPARATOR
Intervention: Control period (no treatment)
Number of subjects: 24
Study 30927126 — intervention group
Group type: COMPARATOR
Intervention: Control (Group A) - Forward alignment training
Number of subjects: 80
Study 30927126 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B - Increasing sensorimotor discordance
Number of subjects: 80
Study 30927126 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C - Decreasing sensorimotor discordance
Number of subjects: 80
Study 30927126 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D - Varied sensorimotor discordance
Number of subjects: 80
Study 30927126 — intervention group
Group type: EXPERIMENTAL
Intervention: Side alignment training
Number of subjects: 80
Study 30927126 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse alignment training
Number of subjects: 80
Study 29140382 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini Dental Implants (MDIs) - 4 implants
Number of subjects: 50
Study 29140382 — intervention group
Group type: COMPARATOR
Intervention: Standard-Sized Tissue-Level Implants (STL) - 2 implants
Number of subjects: 50
Study 24550352 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular physical exercise in senior sportsmen
Number of subjects: 3
Study 24550352 — intervention group
Group type: COMPARATOR
Intervention: Sedentary seniors
Number of subjects: 3
Study 23739274 — intervention group
Group type: EXPERIMENTAL
Intervention: Day AFO-wearing group (n = 56, wearing AFOs all day)
Number of subjects: 112
Study 23739274 — intervention group
Group type: COMPARATOR
Intervention: Day-night AFO-wearing group (n = 56, wearing AFOs all day and all night)
Number of subjects: 112
Study 22165321 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6% triclosan irrigation
Number of subjects: 14
Study 19803565 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance
Number of subjects: 100
Study 19803565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive dissonance
Number of subjects: 100
Study 19803565 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 100
Study 19803565 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study 19803565 — intervention group
Group type: COMPARATOR
Intervention: Ruminative attention control
Number of subjects: 100
Study 17063830 — intervention group
Group type: EXPERIMENTAL
Intervention: LI.11 group (EA at LI.11 acupoint)
Number of subjects: 24
Study 17063830 — intervention group
Group type: EXPERIMENTAL
Intervention: LI.10 group (EA at LI.10 acupoint)
Number of subjects: 24
Study 17063830 — intervention group
Group type: COMPARATOR
Intervention: Control group (without acupuncture)
Number of subjects: 24
Study 15604853 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem-cell therapy (various approaches including direct injection, intravascular injection, and bone marrow stimulation)
Number of subjects: 0
Study 15604853 — intervention group
Group type: EXPERIMENTAL
Intervention: Early clinical trials (various approaches)
Number of subjects: 0
Study 11728954 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine from preterm neonates
Number of subjects: 19
Study 11728954 — intervention group
Group type: COMPARATOR
Intervention: Urine from full-term neonates
Number of subjects: 19
Study 11728954 — intervention group
Group type: COMPARATOR
Intervention: Urine from healthy adults
Number of subjects: 19
Study 11728954 — intervention group
Group type: EXPERIMENTAL
Intervention: Age progression in preterm neonates
Number of subjects: 19
Study 11728954 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between [tm] and urinary citrate level
Number of subjects: 19
Study 9229602 — intervention group
Group type: EXPERIMENTAL
Intervention: Antazolin/Tetryzolin eye drops
Number of subjects: 69
Study 9229602 — intervention group
Group type: COMPARATOR
Intervention: Levocabastine eye drops
Number of subjects: 69
Study 7893587 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate, 200 micrograms twice daily for 2 weeks
Number of subjects: 0
Study 7893587 — intervention group
Group type: COMPARATOR
Intervention: No therapy (Control)
Number of subjects: 0
Study 7893587 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 0
Study 3315279 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum drugs (specific drugs not mentioned)
Number of subjects: 0
Study 3315279 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 29077192 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral inferior oblique graded recession-anteriorization (Group UNI)
Number of subjects: 34
Study 29077192 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral inferior oblique graded recession-anteriorization (Group BI)
Number of subjects: 34
Study 27232535 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous gluconate daily (37.5 mg iron)
Number of subjects: 215
Study 27232535 — intervention group
Group type: COMPARATOR
Intervention: No iron supplementation
Number of subjects: 215
Study 26212249 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic ergometer
Number of subjects: 11
Study 26212249 — intervention group
Group type: COMPARATOR
Intervention: Stationary ergometer
Number of subjects: 11
Study 23902888 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupus enteritis group (n = 66)
Number of subjects: 139
Study 23902888 — intervention group
Group type: COMPARATOR
Intervention: Non-lupus related abdominal pain group (n = 73)
Number of subjects: 139
Study 21916688 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard expressive writing intervention
Number of subjects: 258
Study 21916688 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced expressive writing intervention
Number of subjects: 258
Study 21916688 — intervention group
Group type: COMPARATOR
Intervention: Control condition (nonemotional topic writing)
Number of subjects: 258
Study 19034253 — intervention group
Group type: EXPERIMENTAL
Intervention: H7-insomnia control (acupressure device on HT 7 points)
Number of subjects: 40
Study 19034253 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 40
Study 19034253 — intervention group
Group type: EXPERIMENTAL
Intervention: H7-insomnia control
Number of subjects: 40
Study 16637039 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg)
Number of subjects: 31
Study 15580061 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week low-cholesterol/low-saturated fat diet (30% total fat, 5% saturated fat, cholesterol <200 mg/daily)
Number of subjects: 35
Study 11349386 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg)
Number of subjects: 8
Study 11349386 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (75 mg)
Number of subjects: 8
Study 11349386 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg)
Number of subjects: 8
Study 11349386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 9209604 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone (1.0 mg/kg bolus followed by 10 micrograms/kg/min)
Number of subjects: 20
Study 9209604 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine (5 micrograms/kg/min)
Number of subjects: 20
Study 7964138 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subgallate (BSG)
Number of subjects: 202
Study 7964138 — intervention group
Group type: COMPARATOR
Intervention: Standard operations (Control)
Number of subjects: 202
Study 3069935 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 22
Study 3069935 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 22
Study 3069935 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 31050932 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser surgery
Number of subjects: 22
Study 31050932 — intervention group
Group type: COMPARATOR
Intervention: Scalpel surgery
Number of subjects: 22
Study 27798452 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified double-injection group (MDI group)
Number of subjects: 90
Study 27798452 — intervention group
Group type: COMPARATOR
Intervention: Traditional double-injection group (DI group)
Number of subjects: 90
Study 26373926 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention including education, decisional support tool, logistical strategies
Number of subjects: 4400
Study 26373926 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention
Number of subjects: 4400
Study 26373926 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (control)
Number of subjects: 4400
Study 23352719 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment (ET) - laser photocoagulation at high-risk prethreshold ROP
Number of subjects: 401
Study 23352719 — intervention group
Group type: COMPARATOR
Intervention: Conventional management (CM) - treatment only if threshold ROP developed
Number of subjects: 401
Study 21421511 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg/day
Number of subjects: 93
Study 21421511 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 93
Study 21421511 — intervention group
Group type: COMPARATOR
Intervention: Control (no lipid-lowering drugs)
Number of subjects: 93
Study 21421511 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (both doses)
Number of subjects: 93
Study 19217695 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% lidocaine cream
Number of subjects: 70
Study 19217695 — intervention group
Group type: EXPERIMENTAL
Intervention: Injected, buffered 1% lidocaine
Number of subjects: 70
Study 19217695 — intervention group
Group type: COMPARATOR
Intervention: No local anesthesia
Number of subjects: 70
Study 17760733 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1500 mg daily for 24 weeks
Number of subjects: 48
Study 17760733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 14694502 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg betamethasone and lidocaine
Number of subjects: 81
Study 14694502 — intervention group
Group type: COMPARATOR
Intervention: 1 ml saline placebo and lidocaine
Number of subjects: 81
Study 14694502 — intervention group
Group type: EXPERIMENTAL
Intervention: serial steroid injections
Number of subjects: 81
Study 11601817 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (200 ml, 2000000 kallikrein inactivator units before the operation and then 50 ml per h until the end of the operation)
Number of subjects: 30
Study 11601817 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 30
Study 9855026 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 0
Study 9855026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7971540 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education programmes for specific diseases (heart disease, diabetes mellitus, bowel diseases) during waiting time; preferred mode of dissemination: leaflets.
Number of subjects: 0
Study 7971540 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of religious programmes in health education.
Number of subjects: 0
Study 7971540 — intervention group
Group type: EXPERIMENTAL
Intervention: Activities during waiting time (reading, sleeping, talking).
Number of subjects: 0
Study 7971540 — intervention group
Group type: EXPERIMENTAL
Intervention: Average waiting time.
Number of subjects: 0
Study 3275750 — intervention group
Group type: EXPERIMENTAL
Intervention: A-COP+ regimen (Adriamycin, vincristine, prednisone, cyclophosphamide, methotrexate, hydrocortisone)
Number of subjects: 76
Study 3275750 — intervention group
Group type: EXPERIMENTAL
Intervention: LSA2-L2 regimen (cyclophosphamide, vincristine, methotrexate, Daunomycin, prednisone, cytarabine, thioguanine, asparaginase, hydroxyurea, carmustine)
Number of subjects: 76
Study 3275750 — intervention group
Group type: COMPARATOR
Intervention: A-COP+ regimen
Number of subjects: 76
Study 3275750 — intervention group
Group type: COMPARATOR
Intervention: LSA2-L2 regimen
Number of subjects: 76
Study 31877399 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour change interventions using the RANAS approach
Number of subjects: 1945
Study 31877399 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 1945
Study 29243247 — intervention group
Group type: EXPERIMENTAL
Intervention: Designed Breakfast Glucose Profile (DBGP)
Number of subjects: 51
Study 29243247 — intervention group
Group type: COMPARATOR
Intervention: 75-g Oral Glucose Tolerance Test (OGTT)
Number of subjects: 51
Study 27573312 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine follow-up care
Number of subjects: 24
Study 27573312 — intervention group
Group type: COMPARATOR
Intervention: Traditional care (Control)
Number of subjects: 24
Study 24135832 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA)
Number of subjects: 146
Study 24135832 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic drug therapy (ADT)
Number of subjects: 146
Study 23885611 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture + herb group (group A)
Number of subjects: 42
Study 23885611 — intervention group
Group type: COMPARATOR
Intervention: Heparin sodium group (group B)
Number of subjects: 42
Study 20164324 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-pulse transcranial magnetic stimulation (TMS) applied to the superior temporal sulcus (STS)
Number of subjects: 0
Study 20164324 — intervention group
Group type: COMPARATOR
Intervention: Control location TMS
Number of subjects: 0
Study 17972087 — intervention group
Group type: EXPERIMENTAL
Intervention: TCu-380A
Number of subjects: 100
Study 17075823 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor necrosis factor (TNF) inhibitors (infliximab, etanercept, or adalimumab)
Number of subjects: 100
Study 17075823 — intervention group
Group type: COMPARATOR
Intervention: Ineligible patients (not receiving TNF inhibitors)
Number of subjects: 100
Study 12532160 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT diet (67% of treatment fat as MCT oil, 49% octanoate, 50% decanoate)
Number of subjects: 17
Study 12532160 — intervention group
Group type: COMPARATOR
Intervention: LCT diet (exclusively beef tallow as treatment fat)
Number of subjects: 17
Study 12532160 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT diet
Number of subjects: 17
Study 12532160 — intervention group
Group type: COMPARATOR
Intervention: LCT diet
Number of subjects: 17
Study 10618543 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexavalent meningococcal outer-membrane-vesicle vaccine (7.5 and 15 microg of individual PorA proteins)
Number of subjects: 337
Study 10618543 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexavalent meningococcal outer-membrane-vesicle vaccine
Number of subjects: 337
Study 10618543 — intervention group
Group type: COMPARATOR
Intervention: Control group vaccinated against hepatitis B
Number of subjects: 337
Study 8856250 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 16
Study 8856250 — intervention group
Group type: COMPARATOR
Intervention: Iohexol
Number of subjects: 16
Study 1512396 — intervention group
Group type: EXPERIMENTAL
Intervention: Well Elderly Program (35 students)
Number of subjects: 93
Study 1512396 — intervention group
Group type: COMPARATOR
Intervention: Control group (58 students)
Number of subjects: 93
Study 6394572 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir 400 mg five times a day for five days
Number of subjects: 41
Study 6394572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 30071081 — intervention group
Group type: EXPERIMENTAL
Intervention: WORRK tool used to estimate nRTW risk before allocation to vocational pathways
Number of subjects: 280
Study 30071081 — intervention group
Group type: COMPARATOR
Intervention: Control group without nRTW risk estimation
Number of subjects: 280
Study 26460983 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (single dose of 0.3 mg/kg)
Number of subjects: 226
Study 26460983 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone (1 mg/kg per day for 3 days)
Number of subjects: 226
Study 26460983 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 226
Study 26460983 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 226
Study 24743440 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention aimed at reducing total fat intake and encouraging increased intake of fruit, vegetables, and grains
Number of subjects: 48835
Study 24743440 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 48835
Study 24743440 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 48835
Study 23046401 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment regimen (one‐to‐one education, lifestyle intervention, scheduled clinic visits, strict glucose control, frequent glucose self‐monitoring)
Number of subjects: 275
Study 23046401 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment regimen
Number of subjects: 275
Study 20057309 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent CD4-guided antiretroviral therapy (Drug Conservation group)
Number of subjects: 275
Study 20057309 — intervention group
Group type: COMPARATOR
Intervention: Continuous antiretroviral therapy (Viral Suppression group)
Number of subjects: 275
Study 18555469 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic Scalpel (HS)
Number of subjects: 32
Study 18555469 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery (EC)
Number of subjects: 32
Study 15939547 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term neoadjuvant HT
Number of subjects: 336
Study 15939547 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term neoadjuvant HT
Number of subjects: 336
Study 15939547 — intervention group
Group type: COMPARATOR
Intervention: No neoadjuvant HT
Number of subjects: 336
Study 15939547 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment GU symptoms
Number of subjects: 336
Study 12668495 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial high rate episodes (AHREs) detected by pacemaker diagnostics
Number of subjects: 312